Report for Zameer S

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Effect of the MAGL\/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Abeta, HSP-70, Neuroinflammation, and Oxidative Stress - Bajaj_2022_ACS.Chem.Neurosci__
Author(s) : Bajaj S , Zameer S , Jain S , Yadav V , Vohora D
Ref : ACS Chem Neurosci , : , 2022
Abstract : Bajaj_2022_ACS.Chem.Neurosci__
ESTHER : Bajaj_2022_ACS.Chem.Neurosci__
PubMedSearch : Bajaj_2022_ACS.Chem.Neurosci__
PubMedID: 35316021

Title : Linagliptin, a DPP-4 inhibitor, ameliorates Abeta (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease - Siddiqui_2021_Neuropharmacol__108662
Author(s) : Siddiqui N , Ali J , Parvez S , Zameer S , Najmi AK , Akhtar M
Ref : Neuropharmacology , :108662 , 2021
Abstract : Siddiqui_2021_Neuropharmacol__108662
ESTHER : Siddiqui_2021_Neuropharmacol__108662
PubMedSearch : Siddiqui_2021_Neuropharmacol__108662
PubMedID: 34119519

Title : Alendronate reduces the cognitive and neurological disturbances induced by combined doses of d-galactose and aluminum chloride in mice - Zameer_2021_J.Appl.Toxicol__
Author(s) : Zameer S , Hussain S , Vohora D , Kalam Najmi A , Ali J , Akhtar M
Ref : J Appl Toxicol , : , 2021
Abstract : Zameer_2021_J.Appl.Toxicol__
ESTHER : Zameer_2021_J.Appl.Toxicol__
PubMedSearch : Zameer_2021_J.Appl.Toxicol__
PubMedID: 33694194

Title : Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet - Zameer_2020_Brain.Res.Bull__
Author(s) : Zameer S , Alam M , Hussain S , Vohora D , Ali J , Akhtar M
Ref : Brain Research Bulletin , : , 2020
Abstract : Zameer_2020_Brain.Res.Bull__
ESTHER : Zameer_2020_Brain.Res.Bull__
PubMedSearch : Zameer_2020_Brain.Res.Bull__
PubMedID: 32389800

Title : Bisphosphonates: Future perspective for neurological disorders - Zameer_2018_Pharmacol.Rep_70_900
Author(s) : Zameer S , Najmi AK , Vohora D , Akhtar M
Ref : Pharmacol Rep , 70 :900 , 2018
Abstract : Zameer_2018_Pharmacol.Rep_70_900
ESTHER : Zameer_2018_Pharmacol.Rep_70_900
PubMedSearch : Zameer_2018_Pharmacol.Rep_70_900
PubMedID: 30096489